Literature DB >> 35247153

Targeting Microbial Bio-film: an Update on MDR Gram-Negative Bio-film Producers Causing Catheter-Associated Urinary Tract Infections.

Susmita Chakrabarty1, Monali P Mishra2, Dipankar Bhattacharyay3.   

Abstract

In every age group, urinary tract infection (UTI) is found as a major recurrence infectious disorder. Bio-films produced by bacteria perform a vital role in causing infection in the tract of the urinary system, leading to recurrences and relapses. The purpose of this review is to present the role and mechanism of bio-film producing MDR Gram-negative bacteria causing UTI, their significance, additionally the challenges for remedy and prevention of catheter-associated UTI. This work appreciates a new understanding of bio-film producers which are having multi-drug resistance capability and focuses on the effect and control of bio-film producing uropathogenic bacteria related to catheterization. We have tried to analyze approaches to target bio-film and reported phytochemicals with anti-bio-film activity also updated on anti-bio-film therapy.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acinetobacter baumannii; Antibiotic resistance; Bio-film; CAUTI; Escherichia coli; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2022        PMID: 35247153     DOI: 10.1007/s12010-021-03711-9

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  54 in total

Review 1.  Clinical practice. Uncomplicated urinary tract infection.

Authors:  Thomas M Hooton
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

2.  In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern.

Authors:  Poovendran Ponnusamy; Vidhya Natarajan; Murugan Sevanan
Journal:  Asian Pac J Trop Med       Date:  2012-03       Impact factor: 1.226

Review 3.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 4.  Biofilm formation mechanisms and targets for developing antibiofilm agents.

Authors:  Nira Rabin; Yue Zheng; Clement Opoku-Temeng; Yixuan Du; Eric Bonsu; Herman O Sintim
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

Review 5.  Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms.

Authors:  Heleen Van Acker; Patrick Van Dijck; Tom Coenye
Journal:  Trends Microbiol       Date:  2014-03-02       Impact factor: 17.079

Review 6.  Pseudomonas biofilm matrix composition and niche biology.

Authors:  Ethan E Mann; Daniel J Wozniak
Journal:  FEMS Microbiol Rev       Date:  2012-01-23       Impact factor: 16.408

Review 7.  Catheter-associated urinary tract infections: new aspects of novel urinary catheters.

Authors:  U-Syn Ha; Yong-Hyun Cho
Journal:  Int J Antimicrob Agents       Date:  2006-10-12       Impact factor: 5.283

Review 8.  Urinary tract infections: epidemiology, mechanisms of infection and treatment options.

Authors:  Ana L Flores-Mireles; Jennifer N Walker; Michael Caparon; Scott J Hultgren
Journal:  Nat Rev Microbiol       Date:  2015-04-08       Impact factor: 60.633

9.  Effect of nitroxides on swarming motility and biofilm formation, multicellular behaviors in Pseudomonas aeruginosa.

Authors:  César de la Fuente-Núñez; Fany Reffuveille; Kathryn E Fairfull-Smith; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

10.  Repurposing the anticancer drug mitomycin C for the treatment of persistent Acinetobacter baumannii infections.

Authors:  Martha Yumiko Cruz-Muñiz; Luis Esau López-Jacome; Melissa Hernández-Durán; Rafael Franco-Cendejas; Paula Licona-Limón; Jose Luis Ramos-Balderas; Mariano Martinéz-Vázquez; Javier A Belmont-Díaz; Thomas K Wood; Rodolfo García-Contreras
Journal:  Int J Antimicrob Agents       Date:  2016-10-07       Impact factor: 5.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.